Medicare Part D drug Data year 2024 Generic name Source: CMS Part D Prescribers

Buprenorphine

Open in the dashboard

Part D claims

391,853

Prescriptions dispensed, refills included

Drug cost

$96,994,771

Paid at the pharmacy, in all

Prescribers

8,988

With 11 or more claims of it

In 2024, Medicare Part D recorded 391,853 claims for Buprenorphine from 8,988 prescribers, at a total drug cost of $97 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 52 states and territories

Part D claims for Buprenorphine by the state of the prescriber, 2024
State	Prescribers	Claims	Drug cost
CA	1,000	37,971	$9,052,485
TX	589	28,110	$6,842,153
NC	503	25,262	$6,266,711
GA	356	24,170	$6,493,397
PA	527	21,376	$5,119,748
FL	354	16,848	$3,718,492
OH	323	14,758	$3,594,360
AL	159	14,026	$3,712,895
MI	367	13,947	$3,362,938
OK	193	13,899	$3,438,709
CO	339	13,733	$3,599,137
WA	269	11,745	$2,842,822
TN	238	11,099	$2,769,483
AZ	248	10,380	$2,271,214
SC	184	10,134	$2,507,692

The other 37 states and territories

State	Prescribers	Claims	Drug cost
NY	282	9,169	$2,258,135
MN	189	8,865	$2,407,785
VA	208	8,264	$2,079,032
IN	175	7,738	$2,092,616
MA	176	7,377	$1,608,293
WI	189	5,889	$1,532,695
IL	163	5,620	$1,358,828
MO	146	5,441	$1,361,774
LA	89	5,042	$1,276,977
AR	119	5,025	$1,361,360
CT	109	4,889	$1,103,929
NJ	133	4,864	$1,078,401
UT	121	4,300	$1,157,105
MD	124	4,289	$958,712
NE	90	4,239	$1,112,843
ID	106	4,042	$1,202,381
OR	123	3,608	$890,368
KY	90	3,508	$993,257
ME	62	2,341	$587,552
IA	83	2,023	$516,591
KS	63	2,020	$513,840
WV	49	1,942	$544,035
RI	60	1,941	$434,012
MS	53	1,900	$494,098
DE	35	1,631	$358,655
NH	51	1,604	$372,109
NV	50	1,491	$347,882
MT	55	1,329	$353,078
SD	29	1,129	$304,330
NM	30	802	$177,854
AK	19	662	$194,826
WY	29	601	$170,683
VT	17	292	$82,509
DC	10	215	$44,782
HI	6	193	$39,709
PR	3	72	$20,488
ND	3	38	$11,015

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 51

Part D claims for Buprenorphine by prescriber specialty, 2024
Specialty	Prescribers	Claims	Drug cost
Nurse Practitioner	2,471	113,247	$28,137,517
Physician Assistant	1,288	62,528	$15,752,400
Pain Management	800	46,313	$11,439,225
Anesthesiology	713	41,380	$10,105,977
Family Practice	1,212	28,930	$7,219,399
Physical Medicine and Rehabilitation	612	26,963	$6,734,548
Interventional Pain Management	442	26,919	$6,562,268
Internal Medicine	766	18,072	$4,301,107
Hospice and Palliative Care	185	6,622	$1,471,116
Pharmacist	31	3,118	$738,837
Neurology	71	2,185	$521,434
Addiction Medicine	28	1,925	$488,542
Rheumatology	55	1,557	$387,215
Emergency Medicine	33	1,526	$426,013
General Practice	28	1,238	$330,639

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber	Specialty	State	Claims	Drug cost	Related payments
Raymond Gaeta	Anesthesiology	CA	1,195	$291,221	None on record
James Foster	Nurse Practitioner	WA	852	$171,080	None on record
Hang Tran	Pharmacist	CA	773	$248,183	No profile
Jennifer Holeman	Anesthesiology	OK	762	$191,043	None on record
Enrique Murciano	Anesthesiology	FL	735	$115,323	None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Buprenorphine and Naloxone

$4,856,027 in general payments reported against it, with the companies and doctors behind them.

Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate

$779,489 in general payments reported against it, with the companies and doctors behind them.

Buprenorphine HCL

$544,526 in general payments reported against it, with the companies and doctors behind them.

Buprenorphine

$409,223 in general payments reported against it, with the companies and doctors behind them.

Buprenorphine & Naloxone

$409,223 in general payments reported against it, with the companies and doctors behind them.

Buprenorphine Hydrochloride

$32,461 in general payments reported against it, with the companies and doctors behind them.

Buprenorphine HCl and Naloxone HCl

$18,060 in general payments reported against it, with the companies and doctors behind them.

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for buprenorphine

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.